Long Covid
Conditions
Keywords
COVID-19, Brain Fog
Brief summary
This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.
Detailed description
The goal of this project is to test the feasibility, acceptability and efficacy of an attention training intervention (Attention Process Training; APT-3) as a potential treatment for brain fog symptoms experienced by people with Long-Covid. There already is good empirical evidence to support the idea that the APT-3 treatment is feasible and effective in improving attention in people with acquired brain injuries, but information about its efficacy and acceptability in people with Long-Covid brain fog is lacking.
Interventions
The APT-3 is an evidence-based, standardized computer-based training program that was designed to improve attention skills that underlie higher level cognitive processes (e.g., executive functions and memory).
This group will listen to a pre-determined playlist of music following the same dosing as the attention training group as stated in the arms.
Sponsors
Study design
Intervention model description
First, participants will complete the pre-treatment assessment. Participants then will be randomized to either immediate APT-3 group, delayed APT or Music activity group. The interventions (APT-3 or Music activity) will last 4 weeks. At the end of the intervention participants will undergo another assessment battery, and once again at 1-month post intervention follow-up. Following the maintenance assessment, participants from the Music activity group will have the option to receive the APT-3 intervention. If they accept, they will undergo another assessment battery at the end of the 4-week intervention. Participants from the delayed APT-3 group will undergo the week 5 assessment and will then be offered to enroll in the APT-3 training. If they accept, they will undergo another assessment battery at the end of the 4-week intervention.
Eligibility
Inclusion criteria
* Aged 18-65 years. Live in the Chicagoland area * A history of confirmed SARS-CoV-2 infection. * Subjective reports of cognitive symptoms that interfere with everyday activities, starting on or shortly after SARS-CoV-2 infection. * Continuation or development of Long-Covid brain fog 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanation. * Objective attentional deficits as measured by the Conners CPT-312, and/or the Digit Span subtest (WAIS- III13). * Able to use a keyboard. * Able to understand and communicate in English. * Able to consent independently.
Exclusion criteria
* Being hospitalized due to COVID-19 diagnosis for more than 3 days. * Pre-morbid neurological conditions that could potentially affect cognition, such as Parkinson's Disease, Alzheimer's Dementia, acquired brain injury. * Severe depression. * Currently enrolled in cognitive training or physical exercise training. * Receiving chemotherapy or radiation within last 6 months. * Active substance abuse.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who successfully completed at least 80% of the study tasks sessions | 2 years | Recording the number of participants who completed at least 80% of the study sessions out of the number of all participants who enrolled in the study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of scores in objective attention tests (i.e, CPT 3), pre- and post -intervention | 2 year | The Conners Continuous Performance Test Third Edition™ (Conners CPT 3™) |
Countries
United States
Contacts
Shirley Ryan AbilityLab
Shirley Ryan AbilityLab